Related Experiment Video

Updated: Jul 8, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K

Corrigendum: Defining discriminatory antibody fingerprints in active and latent tuberculosis

Nadege Nziza1, Deniz Cizmeci1, Leela Davies1,2

  • 1Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.

Frontiers in Immunology
|December 11, 2023
PubMed

Abstract:

[This corrects the article DOI: 10.3389/fimmu.2022.856906.].

Keywords:
HIVactive and latent tuberculosisantibodiesbiomarkersdiagnostics

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K

Related Experiment Videos

Last Updated: Jul 8, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

334
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
334

Articles linked to this work by shared authors, journal, and citation graph.

A proteome-wide atlas of humoral immunity to Mycobacterium tuberculosis across the spectrum of disease.

Frontiers in immunology·2026

Infection with Mycobacterium tuberculosis depletes host fatty acids in humans and non-human primates.

EBioMedicine·2026

Inexpensive High-Throughput Multiplexed Cytokine Detection for Tuberculosis Diagnostics Using Amplified Enzymatic Metallization.

ACS sensors·2026

Inexpensive High-Throughput Multiplexed Cytokine Detection for Tuberculosis Diagnostics Using Amplified Enzymatic Metallization.

bioRxiv : the preprint server for biology·2026

Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults.

Human vaccines & immunotherapeutics·2026

IgG4 Neutralization and Sustained Total IgG Fc-Effector Functions Following Repeated SARS-CoV-2 Vaccination with mRNA-1273.

Infectious diseases and therapy·2026

Berberine induces PD-L1 degradation via the autophagy-lysosome pathway through the PI3K-Akt pathway and enhances immunogenic cell death in triple-negative breast cancer.

Frontiers in immunology·2026

Serum interleukin-10 levels and mortality in severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis.

Frontiers in immunology·2026

The auditory nerve glial transition zone is a focal site of age-related immune-myelin interactions.

Frontiers in immunology·2026

Profiling complement proteins in pediatric tuberculosis children with or without serological evidence of prior SARS-CoV-2 exposure.

Frontiers in immunology·2026

Integrated multi-omics analysis reveals dendritic cell centered regulatory networks and therapeutic targets in necrotizing enterocolitis.

Frontiers in immunology·2026

CD161 serves as a prognostic biomarker and predicts immunotherapy response in head and neck squamous cell carcinoma.

Frontiers in immunology·2026

EXPRESS: Discrepancies in widely used serological methods to detect Borrelia infections may cause missed Lyme diagnoses.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

First report of daratumumab interference in urine immunofixation electrophoresis confirmed by the HYDRASHIFT 2/4 Daratumumab assay.

Annals of clinical biochemistry·2026

Analytical interference by IgM paraprotein causing platform-dependent electrolyte discrepancies: a case-based laboratory investigation.

Biochemia medica·2026

Lymphedema: current treatment strategies and future directions in tissue engineering.

Frontiers in medicine·2026

[Establishment and validation of an LC-MS/MS-based determination method for 17-hydroxyprogesterone in canine serum].

Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere·2026

Immunocytochemical staining for lymphatic and blood vessels with frozen sections: using LYVE-1 for lymphatic vessel and von Willebrand factor for blood vessel marker.

European journal of histochemistry : EJH·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us